Enveric Biosciences filed to prospectus supplement to offer 228,690 shares at a deemed offering price of $1.41 per share directly to certain investors in a registered direct offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ENVB:
- Here’s What You Missed in Cannabis, Psychedelics This Week
- Enveric in compound out-licensing deal with biotech firm with
- Enveric Biosciences Plans to Out-License Compound Classes
- Enveric Biosciences to sell cancer-related patent portfolio, terms undisclosed
- Enveric Biosciences Unveils New Mental Health Compounds